Chronos Archive seal

Review checklist: Liliʻuokalani (HR-ET024)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the ABCD2 score and same-day pathway, dual antiplatelet loading about 18 hours after onset, the tissue-based change from TIA to minor stroke, atorvastatin 40 mg in a 78-year-old woman, starting losartan one week after the event, 30-day monitoring, the switch to full-dose apixaban at five weeks, the missed two-week potassium check, the nosebleed management, and lomilomi on an anticoagulant.
provenance reviewnot_startedSources: the Liliʻuokalani Trust, the State of Hawaiʻi's Washington Place timeline, Public Law 103-150, her 1898 memoir (University of Pennsylvania digital library) and a Rutgers University Libraries article. ʻIolani Palace, the Hawaiʻi State Archives' digital collections, the Library of Congress and Chronicling America pages could not be fetched. The date and course of her final stroke or strokes are not documented in the sources read.
safe messaging reviewnot_startedThe overthrow, imprisonment and forced abdication are recorded as history, in the words of the 1993 Apology Resolution where possible, and not as symptoms; no trauma diagnosis is made. Native Hawaiian healing is offered without probing, and no practice or ceremony is described. No relative or other historical person is given a modern statement, decision or health fact; ʻohana members are unnamed and synthetic.

Judgment calls (dossier editorial resolutions)

  1. Sources. The case relies on the Liliʻuokalani Trust (the trust she founded), the State of Hawaiʻi's Washington Place timeline, Public Law 103-150, her own 1898 memoir and a Rutgers University Libraries article. ʻIolani Palace's website, the Hawaiʻi State Archives' digital collections, the Library of Congress and its Chronicling America newspapers (including the Honolulu Star-Bulletin report of her death) could not be fetched (blocked). Wikipedia and popular sites found in searches were not used.
  2. Recent-death rule. She died in 1917, so the rule does not apply. A sick visit is included.
  3. Final illness. The Liliʻuokalani Trust says she “dies from a stroke at the age of 79,” and a Rutgers University Libraries article that she “suffered a stroke and died in 1917”; Washington Place gives the date and place. No source read gives the date of the stroke, whether there was more than one, or a decline over months; secondary accounts that describe failing health in the weeks before her death were not used because their sources could not be read. The claim (CLM-0012) is D with certainty “probable” and states what is not documented; no claim about strokes earlier in 1917 or a months-long decline is made. The modern minor stroke (I63.412) is linked to this claim (placement both_with_link); nothing in the record says she had atrial fibrillation or a stroke in March 1917.
  4. Index age and dates. The index visit on March 16, 2026 maps to March 16, 1917, when she was 78 and living at Washington Place in Honolulu, her home for 55 years. The visits on March 17, April 20, May 18, June 15, July 13 and August 24, 2026 map to the same days of 1917, before her 79th birthday and well before her death on November 11, 1917. Her day-to-day whereabouts in 1917 are not documented in the sources read; nothing places her away from Honolulu. The synthetic date of birth is 1947-09-02, a shift of 109 years. No medical history before 1917 is documented in the sources read (her memoir mentions periods of poor health without diagnoses), so the past medical history is empty.
  5. Name. She is known by a single name, Liliʻuokalani, written throughout with the ʻokina (U+02BB) in the display name, aliases and notes. identity.name_parts is used, as for other people known by a single name: her single name is in the family-name field with no given name, so the C-CDA and FHIR names are not split. The notes call her Liliʻuokalani, as she asked in the modern episode, not “Mrs. Dominis.” The aliases are her birth name in the Liliʻuokalani Trust's form, Lydia Liliʻu Loloku Walania Wewehi Kamakaʻeha (the roster brief omitted “Wewehi”), and her baptismal name, Lydia Kamakaʻeha Pākī (the Trust and Washington Place). Neither appears in any other record. The married name “Lydia K. Dominis” was not used because no source read gives it in that form; English-language sources of the period often omit the ʻokina and kahakō, as in Public Law 103-150 and her memoir, and those quotations are left as written.
  6. Overthrow and imprisonment. The overthrow, imprisonment and forced abdication are documented (CLM-0007, CLM-0008) and described in the words of the 1993 Apology Resolution where possible. They are recorded as history and in a trauma-informed social history, not as symptoms; no trauma diagnosis is made. The modern clinicians acknowledge this history when she raises it and do not probe it.
  7. Native Hawaiian healing. Lomilomi through Ke Ola Mamo, a real Native Hawaiian Health Care System that lists lomilomi among its services, and hoʻoponopono with her ʻohana as they choose, are offered alongside clinic care. No practice or ceremony is described. Whether Ke Ola Mamo offers hoʻoponopono was not checked, so the record does not say it does. The one clinical interaction recorded is that a bodywork practitioner should be told she takes an anticoagulant and use gentle pressure.
  8. ʻOhana and other people. Her ʻohana members, the member of her household who drives her, her health care agent (whom she raised as hānai) and her minister are synthetic and unnamed, and no relative or historical person is given a modern statement, decision or health fact. Her parents, hānai parents, husband, brother and the officials of 1893 appear only in claims. The decisions in the modern episode are hers.
  9. Care setting. The project facility name (St. Posthumous Health Center) is kept; in the notes it is a clinic in Honolulu with an affiliated emergency department and a rapid-access stroke clinic. Her modern home is Washington Place, following the documented history, although it is now the Governor's residence; this is a modeling choice, not a claim.
  10. Presenting problem and diagnosis. The presenting problem is transient right hand weakness and word-finding difficulty with a suspected TIA (G45.9, verification provisional), resolved at the stroke clinic the next day when diffusion MRI showed an infarct: a minor ischemic stroke by the tissue-based definition (I63.412, embolic pattern in the left middle cerebral artery territory). Paroxysmal atrial fibrillation (I48.0) was recorded at five weeks from the 30-day monitor. Hypertension (I10) was recorded at intake from her history of untreated borderline readings.
  11. Atrial fibrillation decision. Atrial fibrillation is found (six episodes, burden about 3%, none felt) and anticoagulation is started: apixaban 5 mg twice daily (CHA2DS2-VASc 6, HAS-BLED 2), full dose because she meets only one dose-reduction criterion (weight 58 kg). Clopidogrel was stopped the same day; aspirin had stopped at day 21.
  12. Clinical judgment calls. (1) Same-day emergency evaluation for an ABCD2 score of 5 with presentation about 18 hours after onset, and dual antiplatelet loading within 24 hours after CT. (2) MRI and echocardiogram at the stroke clinic the next morning rather than the same day. (3) 21 days of aspirin and clopidogrel (CHANCE), then clopidogrel alone until anticoagulation. (4) Atorvastatin 40 mg rather than 80 mg in a 78-year-old woman weighing 58 kg; LDL 132 to 64 mg/dL. (5) Losartan 25 mg started one week after the event, when home readings averaged 138/82. (6) No carotid procedure or follow-up imaging for a plaque under 50%. (7) Apixaban started at five weeks, when atrial fibrillation was found. (8) The nosebleed managed without stopping apixaban, with cautery offered and declined in favor of moisturizing.
  13. Disaggregated data. The teaching note's equity point uses the Honolulu study that advises reporting Native Hawaiians separately from other Pacific Islanders; the record does not claim a specific stroke rate for Native Hawaiians.
  14. Synthetic clinical picture. Everything in the modern episode is synthetic: the symptoms, every blood pressure (including home averages, which are narrative), all laboratory values, the ECG, CT, CT angiography, MRI, echocardiogram and monitor findings, every score (NIH Stroke Scale, MoCA, PHQ-2, PHQ-9, modified Rankin Scale, Mini-Cog, AUDIT-C; ABCD2, CHA2DS2-VASc, HAS-BLED, STOP-Bang and the Timed Up and Go are narrative), the screening results (hepatitis C and DXA, narrative), medicines and outcomes. Height (160 cm) and weights are synthetic. Reference ranges are typical adult female ranges.
  15. Sick visit. An anterior nosebleed four weeks into apixaban, chosen because it follows from the treatment and insinuates no undocumented diagnosis: a dry, crusted septum, an unchanged hemoglobin, pressure and nasal moisturizing under the AAO-HNS guideline, and anticoagulation continued. It is not a historical claim.
  16. Annual wellness visit. A subsequent annual wellness visit at 78 (HCPCS G0439 and CPT 99497 in plain text). Judgment calls: PCV20 and RSV given that day, with zoster and Tdap at the next visit and influenza and COVID-19 in the autumn; mammograms and colorectal screening stopped by her choice after discussion; a repeat DXA because of falls risk on an anticoagulant; hepatitis C screening at 78; advance care planning with an unnamed hānai relative as agent, recording that her own Hawaiian practices are to be respected as she and her ʻohana choose, without describing them.
  17. Focused visits. The four chronic-care follow-ups (the stroke clinic the next morning, five weeks, three months and five months) are documented as focused visits on the CMID stroke and transient ischemic attack, atrial fibrillation and hypertension monographs, the 2021 AHA/ASA guideline, the 2021 AHA/ASA primary care statement and the 2023 atrial fibrillation guideline. One deviation is recorded instead of an invented result: the potassium and creatinine check due two weeks after losartan was started was missed because the member of her household who drives her was away; the check at four weeks was normal (potassium 4.5 mmol/L, creatinine 0.86 mg/dL), so no harm resulted; the corrective action was tests at clinic visits or at home by the clinic's nurse. Rehabilitation and follow-up carotid imaging are recorded as not indicated, with reasons. Synthetic findings introduced: the atrial fibrillation, the nosebleed, the osteopenia and the full functional recovery.
  18. Consultation. The vascular neurology referral and the consultation by Henrik Abernethy-Sato, MD (a fictional consultant), at the rapid-access stroke clinic the morning after the index visit, are S. The consultant answers the five referral questions in line with what the record shows afterwards: a minor ischemic stroke of embolic pattern rather than a TIA; 21 days of aspirin and clopidogrel, then clopidogrel alone; 30 days of monitoring, and apixaban 5 mg twice daily in place of clopidogrel if atrial fibrillation is found (as happened at five weeks); no carotid procedure; and targets below 130/80 mmHg and 70 mg/dL with losartan if home readings stayed high, and screening for swallowing, cognition, mood, sleep apnea and falls. The three-month video review with vascular neurology is narrative only.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-04-20
Progress note 03 (C-CDA)
Potassium and creatinine after starting an angiotensin receptor blockerAbout two weeks after starting, then every six monthsThe check due two weeks after losartan was started was missed: the member of her household who drives her was away, and she did not ask anyone else. Today, four weeks after the start, potassium is 4.5 mmol/L and creatinine 0.86 mg/dL (eGFR 69), both normal, so no harm resulted. Corrective action: tests drawn at clinic visits, or at home by the clinic's nurse

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-03-17
Progress note 02 (C-CDA)
ImagingECG and prolonged rhythm monitoring for atrial fibrillationOrderedECG at intake: sinus rhythm. 30-day patch monitor applied today
2026-03-17
Progress note 02 (C-CDA)
LaboratoryLipid panel (LDL goal below 70 mg/dL)OrderedLDL 132 mg/dL at intake; atorvastatin 40 mg started; panel due in four to twelve weeks
2026-07-13
Progress note 06 (C-CDA)
PreventionBone density (DXA)OrderedOsteopenia on a scan three years ago; repeat now because a fracture on an anticoagulant carries extra risk
2026-07-13
Progress note 06 (C-CDA)
PreventionHepatitis C screeningOrderedOne-time screening for adults 18 to 79; never tested; blood drawn today, result by telephone

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

None.

Diagnoses not confirmed

ProblemCodeVerificationReason
Transient weakness and clumsiness of the right hand with word-finding difficulty, lasting about 20 minutes and fully resolved, the afternoon before the visit; suspected transient ischemic attack, ABCD2 score 5 (high risk); NIH Stroke Scale 0G45.9provisionalSynthetic presenting problem; resolved into the stroke diagnosis when diffusion MRI showed a small infarct at the stroke clinic the next day. Not a claim about her real symptoms.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-03-16Total cholesterol214 mg/dL (high)High
2026-03-16LDL cholesterol132 mg/dL (high)High
2026-03-17Left atrial volume index37 mL/m² (high)High